Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126048581 | 12604858 | 1 | I | 201602 | 20160216 | 20160728 | 20160728 | EXP | US-ALLERGAN-1625227US | ALLERGAN | 59.00 | YR | F | Y | 131.97000 | KG | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126048581 | 12604858 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 300 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 2 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 1.5 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 3 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 100 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 4 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 40 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 5 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 20 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 6 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 40 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 7 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 50 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 8 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | UNK, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 126048581 | 12604858 | 9 | C | TENORETIC | ATENOLOLCHLORTHALIDONE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126048581 | 12604858 | 1 | Torticollis |
| 126048581 | 12604858 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126048581 | 12604858 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126048581 | 12604858 | Blood potassium decreased | |
| 126048581 | 12604858 | Dyspnoea | |
| 126048581 | 12604858 | Nasal congestion | |
| 126048581 | 12604858 | Pneumonia | |
| 126048581 | 12604858 | Productive cough | |
| 126048581 | 12604858 | Respiratory disorder | |
| 126048581 | 12604858 | Secretion discharge |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126048581 | 12604858 | 1 | 20151223 | 20151223 | 0 | |
| 126048581 | 12604858 | 2 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 3 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 4 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 5 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 6 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 7 | 20150923 | 20150923 | 0 | |
| 126048581 | 12604858 | 8 | 2011 | 2011 | 0 |